全國服務咨詢熱線：
18438616290
<b id="grzca"><menuitem id="grzca"></menuitem></b>
18438616290
簡要描述：Isoniazid 54-85-3Isoniazid is an?antibacterial?agent used primarily as a tuberculostatic.
產(chǎn)品型號：abs47027420廠商性質(zhì)：生產(chǎn)廠家更新時間：2025-12-11訪 問 量：707產(chǎn)品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 54-85-3 |
|---|---|---|---|
| 分子式 | C6H7N3O | 純度 | 99% |
| 分子量 | 137.14 | 貨號 | abs47027420 |
| 規(guī)格 | 25mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | used primarily as a tuberculostatic | 應用領域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Isoniazid 54-85-3
| 產(chǎn)品描述 | |
| 描述 | Isoniazid is an?antibacterial?agent used primarily as a tuberculostatic. |
| 純度 | 99% |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 異yan肼；INH；Isonicotinic acid hydrazide；Isonicotinic hydrazide |
| 外觀 | 白色或類白色結(jié)晶性粉末 |
| 可溶性/溶解性 | DMSO : 26 mg/mL (189.6 mM) Ethanol : 26 mg/mL (189.6 mM) Water : 25 mg/mL (182.3 mM) |
| 生物活性 | |
| In vitro(體外研究) | Isoniazid is a prodrug that requires activation by the mycobacterial catalase-peroxidase enzyme (KatG) to an active form that then exerts a lethal effect on an intracellular target or targets. Isoniazid upregulates the expression of an operon containing five FAS II components, including kasA and acpM. Isoniazid results in the accumulation of ACP-bound lipid precursors to mycolic acids that are 26 carbons long and fully saturated. Isoniazid enters the mycobacterial cell by passive diffusion. Isoniazid itself is not toxic to the bacterial cell, but acts as a prodrug and is activated by the mycobacterial enzyme KatG, a multifunctional catalase-peroxidase that has other activities, including peroxynitritase and NADH oxidase. Isoniazid inhibits cell wall lipid synthesis, coupled with the findings that inhibitory INH adducts of NAD+/NADP+ are formed from the isonicotinoyl radical, leading the field away from this area. Isoniazid induces a concentration-dependent (0-40 mM) cytotoxic effect in day-1 treated HepG2 cells and not significantly affected by decreases in intracellular GSH concentrations. |
| In vivo(體內(nèi)研究) | Isoniazid increases CYP2E1 protein, and the 6-hydroxychlorzoxazone formation rate is increased by 2.7 and 2.2-fold in liver and kidney, respectively. Isoniazid decreases liver and kidney 20-HETE content to 34% and 15.6% of control, respectively, without significantly altering tissue 19-HETE concentration. |
| 參考文獻 | |
| 參考文獻 |
|
| 研究領域 | |
| 研究領域 | Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
地址：上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
郵箱：
傳真：